Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

2017 speaker faculty

Industry


Anne Beal

Anne Beal

Chief Patient Officer, Sanofi

Read more

Dr. Anne C. Beal, M.D., M.P.H. is the Chief Patient Officer for Sanofi, a global healthcare leader that discovers, develops and distributes therapeutic solutions for patients. In that role, she is responsible for integrating the patient voice and priorities into all aspects of Sanofi’s work to facilitate development of healthcare solutions that truly meet patients’ needs. She is currently based in Paris.

Dr. Beal joined Sanofi from PCORI (Patient-Centered Outcomes Research Institute), where she was the Deputy Executive Director, Chief Officer for Engagement and the inaugural COO. PCORI is a US-based independent organization that supports comparative effectiveness research guided by patients, caregivers and others to help people make informed decisions and improve healthcare delivery and outcomes. Prior to PCORI, Dr. Beal was president of The Aetna Foundation, the charitable arm of Aetna, and previous to that she directed programs on Quality of Care for Underserved Populations at the Commonwealth Fund.

Cathryn Clary

Cathryn Clary

Global Head, Patient Affairs and Policy, Chief Medical Office, Novartis

Read more

Cathryn M. Clary, MD is Global Head of Patient Affairs and Policy in the Chief Medical & Patient Safety Office, Novartis Global Drug Development. In this role, Cathryn is responsible for ensuring the implementation of Patient Focused Drug Development across Novartis and developing and implementing patient centered policies.

Cathryn received her MD degree from the University of Missouri-Columbia and completed psychiatric residency training at the University of Pennsylvania in Philadelphia.  She practiced psychiatry for 13 years in Delaware, staying actively engaged in clinical research through her membership in the University of Pennsylvania Psychopharmacology Research group.

After receiving an MBA degree from the University of Delaware, Cathryn joined Pfizer in 1996 as Medical Director. Her 13 year career at Pfizer was one of continued advancement and in her last four years, she served as SVP of the US Medical group.. supporting a large portfolio. After leaving Pfizer, Cathryn took a role as Head, US Clinical Development and Medical Affairs at Ipsen, a French biopharmaceutical company, for three years, before joining Novartis. 

Throughout her career, Cathryn has been interested and engaged in public affairs and public speaking on behalf of patients. This has led to engagements such as Congressional testimony on publications of pharmaceutical sponsored research in 2004 and presentations before the Institute of Medicine. She is a Distinguished Life Fellow of the American Psychiatric Association.  Cathryn has also published widely, mainly in psychiatric journals.

Christine MacCracken

Christine MacCracken

Director, Patient Support, Janssen

Read more

Christine MacCracken is Director, Patient Support at the Janssen Pharmaceutical Companies of Johnson and Johnson where she leads strategic identification and implementation of patient-centered initiatives. In this role, she serves as key liaison to New York University School of Medicine and the Compassionate Use Advisory Committee (CompAC). Her focus is on raising organizational awareness around hearing the voice of the patient and recognizing “Every Patient is a Person First”.

Prior to joining the Johnson & Johnson Family of Companies in 2015, Christine was Senior Director, Business Insights at the National Comprehensive Cancer Network (NCCN).In support of people with cancer and the providers who treat them, she closely collaborated with industry, state oncology societies and advocacy groups to disseminate NCCN treatment information through health technology platforms as well as market and outcome research programs.

Christine’s strong passion around hearing the voice of the patient began at the Children’s Hospital of Philadelphia where she was an oncology nurse treating families with life changing diagnoses. With patients and their experience front of mind, she developed an interest in research and joined Radiation Therapy Oncology Group (RTOG) with a focus on quality of life studies. Bridging this interest with pharmaceutical development, she later joined Merck & Co., Inc. with increasing roles of responsibility in clinical research and academic affairs, ultimately sharing her collective experience as an adjunct professor.

Christine resides outside of Philadelphia with husband Tim, and the luckiest dog on earth, Jack. She holds a Bachelor of Science, Nursing from Holy Family University and Master’s Degree, Health Education from Arcadia University.

Debra Reinhard

Debra Reinhard

Lead, Translational Medicine Enabling Solutions, Bristol-Myers Squibb

Read more

A sought-after speaker and subject matter expert with over 28 years in the Pharmaceutical industry, Deb’s career has spanned Corporate and R&D Finance and strategy, as well as broad Informatics roles in support of R&D.  As Head of Translational Medicine Enabling Solutions, she leads a growing organization that plans and executes translational medicine strategies, integrating Discovery, Clinical Development and Translational Research.  She is responsible for the BMS biorepository, redesigning informed consent processes and tools, and ensuring robust operations across all lab partners.  Deb is a core member of TransCelerate’s eConsent initiative creating an industry-aligned position on consent processes and technologies.

Divya Mishra Aidoud

Divya Mishra Aidoud

Associate Director, New Product Planning Market Research, Sanofi

Read more

Divya Aidoud is passionate about generating market knowledge and authentic understanding of consumers to help businesses create offerings that address real problems. For over 16 years, she has led the development of strategic learning plans that keep the consumer’s voice, center-stage.

Divya is currently Associate Director, New Product Planning Market Research for Sanofi Genzyme. Before this, she was Director, Global Market Research and Portfolio Management for Sanofi Biosurgery. In this role she developed a New Product Development commercial process and the first Global Patient Journey Playbook. Prior to Sanofi, Divya held global marketing research roles at Keurig, Proctor & Gamble, Boehringer Ingelheim, and Sunovian.

Divya holds a B.A. in Chemistry from Wellesley College and an MBA from Babson College. She is an avid yogi practitioner and is enjoying being a first-time mom.

Dawn DiCandilo

Dawn DiCandilo

Patient Centricity Excellence Director, AstraZeneca

Read more

Dawn has nineteen years of pharma industry experience with a focus and passion for the Medical Affairs function.  14 of those years were spent in the US market in roles within Medical Affairs operations.  In 2012, she helped establish Global Medical Excellence in AstraZeneca and then went to Japan for 3 years to establish Medical Excellence there.  Much of her experience centered around driving an increase in the contribution and value that Medical Affairs brings through strategic planning, metrics, capability development and communication strategies.

In her role as PaCe Excellence Director, Dawn provides strategic direction and leadership of the capability programs to elevate patient insight and engagement skills to help teams effectively understand patient needs and co-create solutions with patients. She facilitates enterprise-level collaborations to develop robust patient-oriented risk management and governance frameworks.

Doug Noland

Doug Noland

Patient Experience, Executive Director, Astellas

Read more

Doug Noland is the head of Astellas’ newly established Patient Experience organization. He is responsible for delivering results for patients by accelerating the pace and scope of associated organizational change to ensure Astellas’ market leadership in the area of patient experience. He is responsible for engaging with all facets of the organization to align on a true north definition of patient experience to ensure that all strategies, tactics, policies and procedures work across all functions to facilitate the delivery of high quality patient experience and outcomes.

Prior to his current role, Doug led the development and implementation of Astellas’ business-to-business model and comprehensive end-to-end disease state solutions to help Integrated Health Systems deliver improved patient care. He also established Astellas’ Commercial Innovation and Effectiveness group during which time he worked with Astellas president team to drive results through broad and sustainable organizational change.

Gabriela Mondino

Gabriela Mondino

Head of US Public Affairs, Multiple Sclerosis, Sanofi Genzyme

Read more

Gabriela Mondino is dedicated to delivering value to patients so they can focus more on living life and less on their disease. For over fifteen years, she has been devoted to understanding needs and providing solutions to physicians and patients.

Gabriela currently leads the Public Affairs function for Multiple Sclerosis at Sanofi Genzyme. She joined Sanofi in 2013 as Global Marketing Director in osteoarthritis, where she led the shift to patient centricity, integrating the voice of the patient into the business strategy. She built patient marketing capabilities within affiliates and supported the implementation of patient activation programs.

Prior to Sanofi, Gabriela held global marketing positions at Baxter Healthcare, Glaxosmithkline, Kraft Foods and Kimberly-Clark. She speaks four languages and has lived in Argentina, France and the US; her work experience covers five continents and over forty countries.

Originally from Argentina, Gabriela earned her bachelor’s degree at Lawrence University and her Master of Business Administration at Thunderbird School of Global Management. In addition, Gabriela is the founder of VISIONAR, a philanthropic organization that provides scholarships and mentorship to college students in Argentina.

Gavin Corcoran

Gavin Corcoran

Chief Medical Officer, Allergan

Read more

More information coming soon...

Jaye Bea Smalley

Jaye Bea Smalley

Associate Director, Patient Advocacy and Professional Relations - Patient Engagement, Boehringer Ingelheim

Read more

More information coming soon...

Jessica Grossman

Jessica Grossman, MD

Chief Executive Officer, Medicines360

Read more

Dr. Grossman is an experienced and visionary leader in women's health. Currently she is CEO of Medicines360, a non-profit pharmaceutical organization. Medicines360 recently received FDA approval for LILETTA a 52mg hormonal IUD. Previously, she was CEO and President at Sense4Baby, Inc. that was sold to AirStrip, LLC. Prior to that she was a medical director at Ethicon Endo-Surgery, a Johnson and Johnson company. Dr. Grossman was also a Board Member at Medicines360, a non-profit pharmaceutical company. In addition, Dr. Grossman was the founder and President of Gynesonics, an early stage medical device company focused on minimally invasive solutions for women’s health where she raised over $20 million in venture capital financing.

Martin Collyer

Martin Collyer

Chief Operating Officer Patient Recruitment, Bioclinica

Read more

More information coming soon...

Ramana Sonty

Ramana Sonty

Director of Strategy, Janssen Global Medical Organization

Read more

Ramana Sonty, MBBS, PhD, is a Director of Strategy, in the Janssen Global Medical Organization.

Dr. Sonty is a J&J leader who helped launch Janssen’s innovative pilot with NYU called CompAC (Compassionate Use Advisory Committee). The CompAC is a first-of-its-kind independent, expert body providing recommendations on compassionate use requests. The model been expanded to all of Janssen’s assets and is under consideration for adoption more broadly across the industry. Pilot findings have been published in Nature and JAMA.  He has trained in Medicine and Neuroscience.

Ruth Wilson

Ruth Wilson

Global Head of Patient Advocacy, Teva

Read more

More information coming soon...

Shabnam Kazmi

Shabnam Kazmi

Vice President, Patient Access & Adherence, Otsuka America

Read more

More information coming soon...

Susan Bartlett

Susan Bartlett

Principal, Bridgeable

Read more

Susan Bartlett is a service designer and business strategist at Bridgeable, where she helps organizations transform their business using service design. Susan leads multidisciplinary design teams as they understand the complex interactions people have with the world around them, and work to make those interactions more meaningful and effective. Her projects emphasize co-creation with a wide array of stakeholders, applying a holistic, systems-thinking lens to problem solving, and using service design to effect organizational change.

Tom Croce

Tom Croce

Vice President, Global Advocacy Relations, Amgen

Read more

Tom Croce, RPh, oversees development and leads implementation of an integrated strategy involving patient advocacy groups and professional associations. He and the extended Amgen Advocacy Relations team around the globe work collaboratively with these external third-party organizations to align and execute on shared goals across the development life-cycle—from pre-clinical to post-launch and across Amgen’s product portfolio—with the shared vision of improving access to care and health outcomes for patients. Amgen’s new approach to advocacy relations is designed to bring more patient and professional input into how the Company develops and commercializes medicines. Tom and his team put a priority focus on advocating for policies in affiliate markets that are in the best interest of patients.

Tom brings a wealth of experience gained from more than 30 years working in the healthcare industry and with professional associations. He joins Amgen from Shire Pharmaceuticals, where he was head of Global Patient Advocacy. His previous leadership roles have spanned patient and professional advocacy, as well as public affairs, and he has held a leadership role with the American Pharmacists Association.

Patients & Advocates


Cindy Geoghegan

Cindy Geoghegan

Principal, Patient and Partners LLC

Read more

A patient advocate and cancer survivor with decades of health policy, communications and capacity-building experience, Cindy Geoghegan founded Patient & Partners to ensure that the patient perspective is strategically integrated into industry, academic, government and non-profit efforts focused on patient outcomes and clinical benefit. She has founded, transformed and grown several patient-led non-profit organizations, and represents the patient perspective on research projects sponsored by government, academia and industry. She currently serves as an individual patient/caregiver representative on CTTI’s Steering Committee and as a team lead for CTTI’s Mobile Clinical Trials Stakeholder Perceptions project.

Grace Cordovano

Grace Cordovano, PhD

CEO, Enlightening Results;
Private Cancer Patient Advocate

Read more

Upon recognizing significant unmet needs and challenges in patients’ journeys throughout their cancer diagnosis, Dr. Grace Cordovano founded Enlightening Results, LLC in 2010. As the culmination of her life’s experiential learning and education, Dr. Cordovano is dedicated to fostering private, personalized patient advocacy services, specializing in the cancer arena.  She strategically and empathetically guides her clients through survivorship or end-of-life care, ensuring they are armed with the most pertinent, medically credible, easy to understand information so as to make empowered decisions about their care. Grace is a firm believer in the continuous advancement and improvement of cancer patient experiences through the infusion of empathic design and thinking into current healthcare paradigms. A frequent questioner of the status quo, she leaves no stone or process unturned in her quest to improve overall patient experiences across the continuum of patient care. She's motivated to have patient and caregiver stories included throughout the entire healthcare ecosystem and considers herself a patient voice activator. Grace operates as part rocket scientist, part healthcare MacGyver, a dash of Tinkerbelle (because everything is better when left with a little sparkle), topped off with a whole lot of coffee. Grace is a proud member of the Alliance of Professional Health Advocates (APHA), the premier, international organization of independent professional patient advocates.

Heidi Floyd

Heidi Floyd

Author, Patient, Advocate, Speaker

Read more

As individuals are diagnosed with cancer, many immediately seek to make a connection with others for help.  Heidi Floyd has become that resource for many. As an author/speaker/patient/advocate, she is able to lean on myriad of NGOs and fellow patients in her network. Heidi has the ability to lean in and listen to true needs – from caregivers and corporations who want to help, but aren’t sure where to begin. Connecting those who need with those who can assist is her true passion, and has done so worldwide. She’s addressed venues as varied as Google to classrooms of 6.

Levi Gershkowitz

Levi Gershkowitz

Founder and Executive Director, Living in the Light LLC

Read more

As a compassionate writer and photographer with a love for people and the stories they carry, Levi is the Founder and Executive Director of Living in the Light, an advocacy corporation that utilizes the potency of photography, filmmaking and compelling personal narratives to educate about the realities of living with a rare disease and the unprecedented impact this has on families and daily life. This distinct concentration grew out of an understanding that the rare disease community is comprised of many people with many voices, while at the heart lies a unified experience of deep resilience and unique wisdom.

Michael Mittelman

Michael Mittelman

VP Patient Advocacy & Strategic Partnerships, American Living Organ Donor Fund
& Patient Editor, The BMJ

Read more

Michael Mittelman is currently the Patient Editor at The BMJ and a Co-Founder and VP of Patient Advocacy and Strategic Partnerships of the American Living Organ Donor Fund, a patient rights group focused on helping living organ donors in their quest to become a donor. He is the former CEO and Co-Founder of PHmHealth, a digital health company focused on post-acute care and compliance. His experience as a patient spans over 3 decades. He is a 3-time kidney transplant recipient with other chronic conditions. Michael was invited to testify/advocate before the FDA and serves as PCORI (Patient-Centered Outcomes Research Institute) patient representative. Additionally, he serves on the steering committee of a PCORI-funded initiative. He has also overseen the mobile app development taskforce and the data governance taskforce for the same PCORI-funded initiative, the NephCure Kidney Network. Michael is a tireless, independent patient advocate and a healthcare strategist. He strongly believes that patients should play integral roles in healthcare companies and government agencies.

Michael holds an MBA in Healthcare Management from the Fox School of Business at Temple University.  He also has a BA in Biological Basis of Behavior from the University of Pennsylvania. He is a published author, with his latest piece in the American Journal of Transplantation.

Marla Jan Wexler

Marla Jan Wexler

Patient, Lupus Advocate and Blogger, Luck Fupus

Read more

MarlaJan Wexler is 35 years old, was born with a complex congenital heart defect, and had 4 open-heart surgeries by the time she was 6. She went from pediatric cardiac ICU patient to pediatric cardiac ICU nurse until being diagnosed with systemic lupus erythematous (lupus). Due to complications from the disease, she was forced her to give up her nursing career. Since 2008 she has been diagnosed with lupus and multiple overlapping autoimmune diseases, cervical cancer, and underwent a double mastectomy December 2014 after a lump was found in her breast.

She’s the creator and author of the blog Luck Fupus (www.luckfupus.com) which she writes about the day-to-day and long-term struggles of living with multiple chronic illnesses. She’s know for her humorous, non-sugar coated, keep-it-real style of writing. Her blog was used as a platform to help her become a patient leader and influencer, and she now travels the country attending healthcare conferences, speaking publicly sharing her story, educating and advocating for patients across the globe.

Nadia Bodkin

Nadia Bodkin

Pharm.D., M.S., Board Member, EDSers United Foundation

Read more

Nadia is a seasoned rare disease advocate. She served as the chairperson for Rare NJ and was the Executive Director for RDUF. She also founded and currently directs EDSers United, and is the current Corporate Engagement Manager for the Jansen’s Foundation. Nadia earned her Pharm.D. and Masters in Genetics from Rutgers University. In addition to leading the community outreach and engagement efforts for LITL, Nadia also formulates and implements collaborative programs specific to the particularities of the rare disease community for several groups dedicated to serving rare disease stakeholders.

All Speakers


Anne Beal

Anne Beal

Chief Patient Officer, Sanofi

Read more

Dr. Anne C. Beal, M.D., M.P.H. is the Chief Patient Officer for Sanofi, a global healthcare leader that discovers, develops and distributes therapeutic solutions for patients. In that role, she is responsible for integrating the patient voice and priorities into all aspects of Sanofi’s work to facilitate development of healthcare solutions that truly meet patients’ needs. She is currently based in Paris.

Dr. Beal joined Sanofi from PCORI (Patient-Centered Outcomes Research Institute), where she was the Deputy Executive Director, Chief Officer for Engagement and the inaugural COO. PCORI is a US-based independent organization that supports comparative effectiveness research guided by patients, caregivers and others to help people make informed decisions and improve healthcare delivery and outcomes. Prior to PCORI, Dr. Beal was president of The Aetna Foundation, the charitable arm of Aetna, and previous to that she directed programs on Quality of Care for Underserved Populations at the Commonwealth Fund.

Cathryn Clary

Cathryn Clary

Global Head, Patient Affairs and Policy, Chief Medical Office, Novartis

Read more

Cathryn M. Clary, MD is Global Head of Patient Affairs and Policy in the Chief Medical & Patient Safety Office, Novartis Global Drug Development. In this role, Cathryn is responsible for ensuring the implementation of Patient Focused Drug Development across Novartis and developing and implementing patient centered policies.

Cathryn received her MD degree from the University of Missouri-Columbia and completed psychiatric residency training at the University of Pennsylvania in Philadelphia.  She practiced psychiatry for 13 years in Delaware, staying actively engaged in clinical research through her membership in the University of Pennsylvania Psychopharmacology Research group.

After receiving an MBA degree from the University of Delaware, Cathryn joined Pfizer in 1996 as Medical Director. Her 13 year career at Pfizer was one of continued advancement and in her last four years, she served as SVP of the US Medical group.. supporting a large portfolio. After leaving Pfizer, Cathryn took a role as Head, US Clinical Development and Medical Affairs at Ipsen, a French biopharmaceutical company, for three years, before joining Novartis. 

Throughout her career, Cathryn has been interested and engaged in public affairs and public speaking on behalf of patients. This has led to engagements such as Congressional testimony on publications of pharmaceutical sponsored research in 2004 and presentations before the Institute of Medicine. She is a Distinguished Life Fellow of the American Psychiatric Association.  Cathryn has also published widely, mainly in psychiatric journals.

Christine MacCracken

Christine MacCracken

Director, Patient Support, Janssen

Read more

Christine MacCracken is Director, Patient Support at the Janssen Pharmaceutical Companies of Johnson and Johnson where she leads strategic identification and implementation of patient-centered initiatives. In this role, she serves as key liaison to New York University School of Medicine and the Compassionate Use Advisory Committee (CompAC). Her focus is on raising organizational awareness around hearing the voice of the patient and recognizing “Every Patient is a Person First”.

Prior to joining the Johnson & Johnson Family of Companies in 2015, Christine was Senior Director, Business Insights at the National Comprehensive Cancer Network (NCCN).In support of people with cancer and the providers who treat them, she closely collaborated with industry, state oncology societies and advocacy groups to disseminate NCCN treatment information through health technology platforms as well as market and outcome research programs.

Christine’s strong passion around hearing the voice of the patient began at the Children’s Hospital of Philadelphia where she was an oncology nurse treating families with life changing diagnoses. With patients and their experience front of mind, she developed an interest in research and joined Radiation Therapy Oncology Group (RTOG) with a focus on quality of life studies. Bridging this interest with pharmaceutical development, she later joined Merck & Co., Inc. with increasing roles of responsibility in clinical research and academic affairs, ultimately sharing her collective experience as an adjunct professor.

Christine resides outside of Philadelphia with husband Tim, and the luckiest dog on earth, Jack. She holds a Bachelor of Science, Nursing from Holy Family University and Master’s Degree, Health Education from Arcadia University.

Debra Reinhard

Debra Reinhard

Lead, Translational Medicine Enabling Solutions, Bristol-Myers Squibb

Read more

A sought-after speaker and subject matter expert with over 28 years in the Pharmaceutical industry, Deb’s career has spanned Corporate and R&D Finance and strategy, as well as broad Informatics roles in support of R&D.  As Head of Translational Medicine Enabling Solutions, she leads a growing organization that plans and executes translational medicine strategies, integrating Discovery, Clinical Development and Translational Research.  She is responsible for the BMS biorepository, redesigning informed consent processes and tools, and ensuring robust operations across all lab partners.  Deb is a core member of TransCelerate’s eConsent initiative creating an industry-aligned position on consent processes and technologies.

Divya Mishra Aidoud

Divya Mishra Aidoud

Associate Director, New Product Planning Market Research, Sanofi

Read more

Divya Aidoud is passionate about generating market knowledge and authentic understanding of consumers to help businesses create offerings that address real problems. For over 16 years, she has led the development of strategic learning plans that keep the consumer’s voice, center-stage.

Divya is currently Associate Director, New Product Planning Market Research for Sanofi Genzyme. Before this, she was Director, Global Market Research and Portfolio Management for Sanofi Biosurgery. In this role she developed a New Product Development commercial process and the first Global Patient Journey Playbook. Prior to Sanofi, Divya held global marketing research roles at Keurig, Proctor & Gamble, Boehringer Ingelheim, and Sunovian.

Divya holds a B.A. in Chemistry from Wellesley College and an MBA from Babson College. She is an avid yogi practitioner and is enjoying being a first-time mom.

Dawn DiCandilo

Dawn DiCandilo

Patient Centricity Excellence Director, AstraZeneca

Read more

Dawn has nineteen years of pharma industry experience with a focus and passion for the Medical Affairs function.  14 of those years were spent in the US market in roles within Medical Affairs operations.  In 2012, she helped establish Global Medical Excellence in AstraZeneca and then went to Japan for 3 years to establish Medical Excellence there.  Much of her experience centered around driving an increase in the contribution and value that Medical Affairs brings through strategic planning, metrics, capability development and communication strategies.

In her role as PaCe Excellence Director, Dawn provides strategic direction and leadership of the capability programs to elevate patient insight and engagement skills to help teams effectively understand patient needs and co-create solutions with patients. She facilitates enterprise-level collaborations to develop robust patient-oriented risk management and governance frameworks.

Doug Noland

Doug Noland

Patient Experience, Executive Director, Astellas

Read more

Doug Noland is the head of Astellas’ newly established Patient Experience organization. He is responsible for delivering results for patients by accelerating the pace and scope of associated organizational change to ensure Astellas’ market leadership in the area of patient experience. He is responsible for engaging with all facets of the organization to align on a true north definition of patient experience to ensure that all strategies, tactics, policies and procedures work across all functions to facilitate the delivery of high quality patient experience and outcomes.

Prior to his current role, Doug led the development and implementation of Astellas’ business-to-business model and comprehensive end-to-end disease state solutions to help Integrated Health Systems deliver improved patient care. He also established Astellas’ Commercial Innovation and Effectiveness group during which time he worked with Astellas president team to drive results through broad and sustainable organizational change.

Gabriela Mondino

Gabriela Mondino

Head of US Public Affairs, Multiple Sclerosis, Sanofi Genzyme

Read more

Gabriela Mondino is dedicated to delivering value to patients so they can focus more on living life and less on their disease. For over fifteen years, she has been devoted to understanding needs and providing solutions to physicians and patients.

Gabriela currently leads the Public Affairs function for Multiple Sclerosis at Sanofi Genzyme. She joined Sanofi in 2013 as Global Marketing Director in osteoarthritis, where she led the shift to patient centricity, integrating the voice of the patient into the business strategy. She built patient marketing capabilities within affiliates and supported the implementation of patient activation programs.

Prior to Sanofi, Gabriela held global marketing positions at Baxter Healthcare, Glaxosmithkline, Kraft Foods and Kimberly-Clark. She speaks four languages and has lived in Argentina, France and the US; her work experience covers five continents and over forty countries.

Originally from Argentina, Gabriela earned her bachelor’s degree at Lawrence University and her Master of Business Administration at Thunderbird School of Global Management. In addition, Gabriela is the founder of VISIONAR, a philanthropic organization that provides scholarships and mentorship to college students in Argentina.

Gavin Corcoran

Gavin Corcoran

Chief Medical Officer, Allergan

Read more

More information coming soon...

Jaye Bea Smalley

Jaye Bea Smalley

Associate Director, Patient Advocacy and Professional Relations - Patient Engagement, Boehringer Ingelheim

Read more

More information coming soon...

Jessica Grossman

Jessica Grossman, MD

Chief Executive Officer, Medicines360

Read more

Dr. Grossman is an experienced and visionary leader in women's health. Currently she is CEO of Medicines360, a non-profit pharmaceutical organization. Medicines360 recently received FDA approval for LILETTA a 52mg hormonal IUD. Previously, she was CEO and President at Sense4Baby, Inc. that was sold to AirStrip, LLC. Prior to that she was a medical director at Ethicon Endo-Surgery, a Johnson and Johnson company. Dr. Grossman was also a Board Member at Medicines360, a non-profit pharmaceutical company. In addition, Dr. Grossman was the founder and President of Gynesonics, an early stage medical device company focused on minimally invasive solutions for women’s health where she raised over $20 million in venture capital financing.

Martin Collyer

Martin Collyer

Chief Operating Officer Patient Recruitment, Bioclinica

Read more

More information coming soon...

Ramana Sonty

Ramana Sonty

Director of Strategy, Janssen Global Medical Organization

Read more

Ramana Sonty, MBBS, PhD, is a Director of Strategy, in the Janssen Global Medical Organization.

Dr. Sonty is a J&J leader who helped launch Janssen’s innovative pilot with NYU called CompAC (Compassionate Use Advisory Committee). The CompAC is a first-of-its-kind independent, expert body providing recommendations on compassionate use requests. The model been expanded to all of Janssen’s assets and is under consideration for adoption more broadly across the industry. Pilot findings have been published in Nature and JAMA.  He has trained in Medicine and Neuroscience.

Ruth Wilson

Ruth Wilson

Global Head of Patient Advocacy, Teva

Read more

More information coming soon...

Shabnam Kazmi

Shabnam Kazmi

Vice President, Patient Access & Adherence, Otsuka America

Read more

More information coming soon...

Susan Bartlett

Susan Bartlett

Principal, Bridgeable

Read more

Susan Bartlett is a service designer and business strategist at Bridgeable, where she helps organizations transform their business using service design. Susan leads multidisciplinary design teams as they understand the complex interactions people have with the world around them, and work to make those interactions more meaningful and effective. Her projects emphasize co-creation with a wide array of stakeholders, applying a holistic, systems-thinking lens to problem solving, and using service design to effect organizational change.

Tom Croce

Tom Croce

Vice President, Global Advocacy Relations, Amgen

Read more

Tom Croce, RPh, oversees development and leads implementation of an integrated strategy involving patient advocacy groups and professional associations. He and the extended Amgen Advocacy Relations team around the globe work collaboratively with these external third-party organizations to align and execute on shared goals across the development life-cycle—from pre-clinical to post-launch and across Amgen’s product portfolio—with the shared vision of improving access to care and health outcomes for patients. Amgen’s new approach to advocacy relations is designed to bring more patient and professional input into how the Company develops and commercializes medicines. Tom and his team put a priority focus on advocating for policies in affiliate markets that are in the best interest of patients.

Tom brings a wealth of experience gained from more than 30 years working in the healthcare industry and with professional associations. He joins Amgen from Shire Pharmaceuticals, where he was head of Global Patient Advocacy. His previous leadership roles have spanned patient and professional advocacy, as well as public affairs, and he has held a leadership role with the American Pharmacists Association.

Cindy Geoghegan

Cindy Geoghegan

Principal, Patient and Partners LLC

Read more

A patient advocate and cancer survivor with decades of health policy, communications and capacity-building experience, Cindy Geoghegan founded Patient & Partners to ensure that the patient perspective is strategically integrated into industry, academic, government and non-profit efforts focused on patient outcomes and clinical benefit. She has founded, transformed and grown several patient-led non-profit organizations, and represents the patient perspective on research projects sponsored by government, academia and industry. She currently serves as an individual patient/caregiver representative on CTTI’s Steering Committee and as a team lead for CTTI’s Mobile Clinical Trials Stakeholder Perceptions project.

Grace Cordovano

Grace Cordovano, PhD

CEO, Enlightening Results;
Private Cancer Patient Advocate

Read more

Upon recognizing significant unmet needs and challenges in patients’ journeys throughout their cancer diagnosis, Dr. Grace Cordovano founded Enlightening Results, LLC in 2010. As the culmination of her life’s experiential learning and education, Dr. Cordovano is dedicated to fostering private, personalized patient advocacy services, specializing in the cancer arena.  She strategically and empathetically guides her clients through survivorship or end-of-life care, ensuring they are armed with the most pertinent, medically credible, easy to understand information so as to make empowered decisions about their care. Grace is a firm believer in the continuous advancement and improvement of cancer patient experiences through the infusion of empathic design and thinking into current healthcare paradigms. A frequent questioner of the status quo, she leaves no stone or process unturned in her quest to improve overall patient experiences across the continuum of patient care. She's motivated to have patient and caregiver stories included throughout the entire healthcare ecosystem and considers herself a patient voice activator. Grace operates as part rocket scientist, part healthcare MacGyver, a dash of Tinkerbelle (because everything is better when left with a little sparkle), topped off with a whole lot of coffee. Grace is a proud member of the Alliance of Professional Health Advocates (APHA), the premier, international organization of independent professional patient advocates.

Heidi Floyd

Heidi Floyd

Author, Patient, Advocate, Speaker

Read more

As individuals are diagnosed with cancer, many immediately seek to make a connection with others for help.  Heidi Floyd has become that resource for many. As an author/speaker/patient/advocate, she is able to lean on myriad of NGOs and fellow patients in her network. Heidi has the ability to lean in and listen to true needs – from caregivers and corporations who want to help, but aren’t sure where to begin. Connecting those who need with those who can assist is her true passion, and has done so worldwide. She’s addressed venues as varied as Google to classrooms of 6.

Levi Gershkowitz

Levi Gershkowitz

Founder and Executive Director, Living in the Light LLC

Read more

As a compassionate writer and photographer with a love for people and the stories they carry, Levi is the Founder and Executive Director of Living in the Light, an advocacy corporation that utilizes the potency of photography, filmmaking and compelling personal narratives to educate about the realities of living with a rare disease and the unprecedented impact this has on families and daily life. This distinct concentration grew out of an understanding that the rare disease community is comprised of many people with many voices, while at the heart lies a unified experience of deep resilience and unique wisdom.

Michael Mittelman

Michael Mittelman

VP Patient Advocacy & Strategic Partnerships, American Living Organ Donor Fund
& Patient Editor, The BMJ

Read more

Michael Mittelman is currently the Patient Editor at The BMJ and a Co-Founder and VP of Patient Advocacy and Strategic Partnerships of the American Living Organ Donor Fund, a patient rights group focused on helping living organ donors in their quest to become a donor. He is the former CEO and Co-Founder of PHmHealth, a digital health company focused on post-acute care and compliance. His experience as a patient spans over 3 decades. He is a 3-time kidney transplant recipient with other chronic conditions. Michael was invited to testify/advocate before the FDA and serves as PCORI (Patient-Centered Outcomes Research Institute) patient representative. Additionally, he serves on the steering committee of a PCORI-funded initiative. He has also overseen the mobile app development taskforce and the data governance taskforce for the same PCORI-funded initiative, the NephCure Kidney Network. Michael is a tireless, independent patient advocate and a healthcare strategist. He strongly believes that patients should play integral roles in healthcare companies and government agencies.

Michael holds an MBA in Healthcare Management from the Fox School of Business at Temple University.  He also has a BA in Biological Basis of Behavior from the University of Pennsylvania. He is a published author, with his latest piece in the American Journal of Transplantation.

Marla Jan Wexler

Marla Jan Wexler

Patient, Lupus Advocate and Blogger, Luck Fupus

Read more

MarlaJan Wexler is 35 years old, was born with a complex congenital heart defect, and had 4 open-heart surgeries by the time she was 6. She went from pediatric cardiac ICU patient to pediatric cardiac ICU nurse until being diagnosed with systemic lupus erythematous (lupus). Due to complications from the disease, she was forced her to give up her nursing career. Since 2008 she has been diagnosed with lupus and multiple overlapping autoimmune diseases, cervical cancer, and underwent a double mastectomy December 2014 after a lump was found in her breast.

She’s the creator and author of the blog Luck Fupus (www.luckfupus.com) which she writes about the day-to-day and long-term struggles of living with multiple chronic illnesses. She’s know for her humorous, non-sugar coated, keep-it-real style of writing. Her blog was used as a platform to help her become a patient leader and influencer, and she now travels the country attending healthcare conferences, speaking publicly sharing her story, educating and advocating for patients across the globe.

Nadia Bodkin

Nadia Bodkin

Pharm.D., M.S., Board Member, EDSers United Foundation

Read more

Nadia is a seasoned rare disease advocate. She served as the chairperson for Rare NJ and was the Executive Director for RDUF. She also founded and currently directs EDSers United, and is the current Corporate Engagement Manager for the Jansen’s Foundation. Nadia earned her Pharm.D. and Masters in Genetics from Rutgers University. In addition to leading the community outreach and engagement efforts for LITL, Nadia also formulates and implements collaborative programs specific to the particularities of the rare disease community for several groups dedicated to serving rare disease stakeholders.

Download the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown